Judith Anne Shizuru insider trades
Open-market stock purchases and sales by Judith Anne Shizuru, Director at Jasper Therapeutics, Inc, from SEC Form 4 filings since Mar 21, 2022.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -83%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 31, 2026 | JSPR Jasper Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- JSPR Jasper Therapeutics, Inc: 1 buy, last Jul 31, 2026
Get free alerts when Judith Anne Shizuru files a new trade →